Clinical Trial

META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia

Name: META 10-19 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia — clinical trial record (NCT07689604)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

A Study of Metabolically Armed Autologous CD19 CAR T-Cell Therapy (META 10-19) in Patients with Relapsed/Refractory Autoimmune Hemolytic Anemia

Trial Details

NCT Number	NCT07689604
Lead Sponsor	Institute of Hematology & Blood Diseases Hospital, China Collaborators: Hangzhou Leman Biotech Co., Ltd
Conditions	Autoimmune Hemolytic Anemia (AIHA)
Enrollment	18 participants
Start Date	2026-07-08
Primary Completion	2027-05-01 (estimated)
Study Completion	2028-10-01 (estimated)
Updated on ClinicalTrials.gov	2026-07-08